IMMUNOCELLULAR THERAPEUTICS's ticker is IMUC and the CUSIP is 452536105. A total of 1 filers reported holding IMMUNOCELLULAR THERAPEUTICS in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $269,000 | -19.5% | 2,277,500 | +56.8% | 0.00% | -100.0% |
| Q2 2016 | $334,000 | -22.0% | 1,452,500 | -1.6% | 0.00% | 0.0% |
| Q1 2016 | $428,000 | -14.4% | 1,476,800 | +4.9% | 0.00% | 0.0% |
| Q4 2015 | $500,000 | +0.8% | 1,407,200 | +19.1% | 0.00% | 0.0% |
| Q3 2015 | $496,000 | -38.3% | 1,181,400 | -30.6% | 0.00% | -50.0% |
| Q2 2015 | $804,000 | +272.2% | 1,702,692 | +281.8% | 0.00% | – |
| Q1 2015 | $216,000 | +184.2% | 446,000 | +327.5% | 0.00% | – |
| Q4 2014 | $76,000 | – | 104,316 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| D'Orazio & Associates, Inc. | 75 | $0 | 0.00% |